Corinne Berclaz1, Anja Schmidt-Christensen2, Daniel Szlag1,3, Jerome Extermann1,4, Lisbeth Hansen2, Arno Bouwens1, Martin Villiger1, Joan Goulley5, Frans Schuit6, Anne Grapin-Botton7, Theo Lasser8, Dan Holmberg9. 1. Laboratoire d'Optique Biomédicale, Ecole Polytechnique Fédérale de Lausanne, CH1015, Lausanne, Switzerland. 2. EMV - Immunology, Lund University, BMC, D14, 221 84, Lund, Sweden. 3. Institute of Physics, Faculty of Physics, Astronomy and Informatics, Nicolaus Copernicus University, Torun, Poland. 4. Hepia, University of Applied Science of Western Switzerland, Genève, Switzerland. 5. Swiss Institute for Experimental Cancer Research, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland. 6. Gene Expression Unit, Department of Molecular and Cellular Medicine, Katholieke Universiteit Leuven, Leuven, Belgium. 7. DanStem, University of Copenhagen, Copenhagen, Denmark. 8. Laboratoire d'Optique Biomédicale, Ecole Polytechnique Fédérale de Lausanne, CH1015, Lausanne, Switzerland. theo.lasser@epfl.ch. 9. EMV - Immunology, Lund University, BMC, D14, 221 84, Lund, Sweden. dan.holmberg@med.lu.se.
Abstract
AIMS/HYPOTHESIS: It is generally accepted that structural and functional quantitative imaging of individual islets would be beneficial to elucidate the pathogenesis of type 1 diabetes. We here introduce functional optical coherence imaging (FOCI) for fast, label-free monitoring of beta cell destruction and associated alterations of islet vascularisation. METHODS: NOD mouse and human islets transplanted into the anterior chamber of the eye (ACE) were imaged with FOCI, in which the optical contrast of FOCI is based on intrinsic variations of the index of refraction resulting in a faster tomographic acquisition. In addition, the phase sensitivity allows simultaneous label-free acquisition of vascularisation. RESULTS: We demonstrate that FOCI allows longitudinal quantification of progressive autoimmune insulitis, including the three-dimensional quantification of beta cell volume, inflammation and vascularisation. The substantially increased backscattering of islets is dominated by the insulin-zinc nanocrystals in the beta cell granules. This translates into a high specificity for the functional beta cell volume of islets. Applying FOCI to a spontaneous mouse model of type 1 diabetes, we quantify the modifications of the pancreatic microvasculature accompanying the progression of diabetes and reveal a strong correlation between increasing insulitis and density of the vascular network of the islet. CONCLUSIONS/ INTERPRETATION: FOCI provides a novel imaging technique for investigating functional and structural diabetes-induced alterations of the islets. The label-free detection of beta cell volume and infiltration together with vascularisation offers a unique extension to study ACE-transplanted human islets. These results are contributing to a deeper understanding of human islet transplant rejection and label-free in vivo monitoring of drug efficacy.
AIMS/HYPOTHESIS: It is generally accepted that structural and functional quantitative imaging of individual islets would be beneficial to elucidate the pathogenesis of type 1 diabetes. We here introduce functional optical coherence imaging (FOCI) for fast, label-free monitoring of beta cell destruction and associated alterations of islet vascularisation. METHODS: NOD mouse and human islets transplanted into the anterior chamber of the eye (ACE) were imaged with FOCI, in which the optical contrast of FOCI is based on intrinsic variations of the index of refraction resulting in a faster tomographic acquisition. In addition, the phase sensitivity allows simultaneous label-free acquisition of vascularisation. RESULTS: We demonstrate that FOCI allows longitudinal quantification of progressive autoimmune insulitis, including the three-dimensional quantification of beta cell volume, inflammation and vascularisation. The substantially increased backscattering of islets is dominated by the insulin-zinc nanocrystals in the beta cell granules. This translates into a high specificity for the functional beta cell volume of islets. Applying FOCI to a spontaneous mouse model of type 1 diabetes, we quantify the modifications of the pancreatic microvasculature accompanying the progression of diabetes and reveal a strong correlation between increasing insulitis and density of the vascular network of the islet. CONCLUSIONS/ INTERPRETATION: FOCI provides a novel imaging technique for investigating functional and structural diabetes-induced alterations of the islets. The label-free detection of beta cell volume and infiltration together with vascularisation offers a unique extension to study ACE-transplanted human islets. These results are contributing to a deeper understanding of human islet transplant rejection and label-free in vivo monitoring of drug efficacy.
Entities:
Keywords:
3D visualisation; Beta cell volume; Human islets; Inflammation; Label-free; Longitudinal; NOD mouse; Non-invasive; OCM; Quantification; Vasculature
Authors: Midhat H Abdulreda; Gaetano Faleo; Ruth Damaris Molano; Maite Lopez-Cabezas; Judith Molina; Yaohong Tan; Oscar A Ron Echeverria; Elsie Zahr-Akrawi; Rayner Rodriguez-Diaz; Patrick K Edlund; Ingo Leibiger; Allison L Bayer; Victor Perez; Camillo Ricordi; Alejandro Caicedo; Antonello Pileggi; Per-Olof Berggren Journal: Proc Natl Acad Sci U S A Date: 2011-07-18 Impact factor: 11.205
Authors: Jason L Gaglia; Alexander R Guimaraes; Mukesh Harisinghani; Stuart E Turvey; Richard Jackson; Christophe Benoist; Diane Mathis; Ralph Weissleder Journal: J Clin Invest Date: 2010-12-01 Impact factor: 14.808
Authors: Tomas Alanentalo; Andreas Hörnblad; Sofia Mayans; Anna Karin Nilsson; James Sharpe; Asa Larefalk; Ulf Ahlgren; Dan Holmberg Journal: Diabetes Date: 2010-04-14 Impact factor: 9.461
Authors: Ken Coppieters; Marianne M Martinic; William B Kiosses; Natalie Amirian; Matthias von Herrath Journal: PLoS One Date: 2010-12-23 Impact factor: 3.240
Authors: Corinne Berclaz; Joan Goulley; Martin Villiger; Christophe Pache; Arno Bouwens; Erica Martin-Williams; Dimitri Van de Ville; Anthony C Davison; Anne Grapin-Botton; Theo Lasser Journal: Biomed Opt Express Date: 2012-05-14 Impact factor: 3.732
Authors: Paul J Marchand; Arno Bouwens; Daniel Szlag; David Nguyen; Adrien Descloux; Miguel Sison; Séverine Coquoz; Jérôme Extermann; Theo Lasser Journal: Biomed Opt Express Date: 2017-06-20 Impact factor: 3.732
Authors: Corinne Berclaz; Daniel Szlag; David Nguyen; Jérôme Extermann; Arno Bouwens; Paul J Marchand; Julia Nilsson; Anja Schmidt-Christensen; Dan Holmberg; Anne Grapin-Botton; Theo Lasser Journal: Biomed Opt Express Date: 2016-10-17 Impact factor: 3.732
Authors: Oscar Alcazar; Luis F Hernandez; Ernesto S Nakayasu; Paul D Piehowski; Charles Ansong; Midhat H Abdulreda; Peter Buchwald Journal: J Proteomics Date: 2020-05-20 Impact factor: 4.044
Authors: Midhat H Abdulreda; R Damaris Molano; Gaetano Faleo; Maite Lopez-Cabezas; Alexander Shishido; Ulisse Ulissi; Carmen Fotino; Luis F Hernandez; Ashley Tschiggfrie; Virginia R Aldrich; Alejandro Tamayo-Garcia; Allison S Bayer; Camillo Ricordi; Alejandro Caicedo; Peter Buchwald; Antonello Pileggi; Per-Olof Berggren Journal: Diabetologia Date: 2019-05-14 Impact factor: 10.122
Authors: Robert A Benson; Fabien Garcon; Asha Recino; John R Ferdinand; Menna R Clatworthy; Herman Waldmann; James M Brewer; Klaus Okkenhaug; Anne Cooke; Paul Garside; Maja Wållberg Journal: Front Immunol Date: 2018-05-18 Impact factor: 7.561